This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
THE NATIONAL Cancer Institute (NCI) is proposing a $10-million to $15million a year project to reduce tobacco use in target populations by applying prevention and cessation techniques being tested in 47 ongoing clinical trials.
The seven- to nine-year project represents an unusually aggressive intervention role for the institute, says Joseph Cullen, PhD. Cullen is deputy director, Division of Cancer Prevention and Control at the NCI, which is part of the National Institutes of Health in Bethesda, Md.
Pending approval by the institute's scientific board next January, the community-based smoking intervention project could be in place by mid 1990, Cullen says. "The goal is to find a more efficient, less costly way to improve interventions and prevent smoking and other use of tobacco, particularly in high-risk groups," he says.
These high-risk target groups include women, youth, members of minority groups, and smokeless tobacco users. These are groups whose continued high rate of
Smoking Prevention/Cessation Drive Can Parallel Continuing Tobacco-Effects Research, NCI Says. JAMA. 1987;258(15):2026. doi:10.1001/jama.1987.03400150016005